Dataset from A Phase 2 Study of Abemaciclib in Patients With Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006546
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and effectiveness of the study drug
known as abemaciclib in participants with hormone receptor positive breast cancer, non-small
cell lung cancer (NSCLC), or melanoma that has spread to the brain.
创建时间：
2025-11-14
